SCHEMBL14083375

SCHEMBL14083375

COc1cccc(NC(=O)c2ccc(-c3ncccc3OC)c(Cl)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.57
▸ RAB9A P51151 4/20 0.57
▸ GRM4 Q14833 1/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.56
▸ KMT2A Q03164 4/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ TP53 P04637 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ PKM P14618 1/20 0.55
▸ TSHR P16473 2/20 0.55
▸ MEN1 O00255 3/20 0.54
▸ KCNK3 O14649 1/20 0.53
▸ KCNK9 Q9NPC2 1/20 0.53
▸ MAPT P10636 3/20 0.53
▸ KCNQ3 O43525 1/20 0.53
▸ KCNQ2 O43526 1/20 0.53
▸ CSF1R P07333 1/20 0.52
▸ NLRP3 Q96P20 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083299 0.91 RXFP1 (0.61) NPC1RAB9AGRM4RXFP1KMT2A
SCHEMBL14083377 0.90 AURKB (0.54) NPC1RAB9AGRM4KMT2ASMN1; SMN2
SCHEMBL14083736 0.90 NPC1 (0.57) NPC1RAB9AGRM4RXFP1KMT2A
SCHEMBL14083380 0.88 GRM4 (0.61) NPC1RAB9AGRM4KMT2ASMN1; SMN2
SCHEMBL14083093 0.88 RXFP1 (0.56) NPC1RAB9AGRM4RXFP1KMT2A
SCHEMBL14083397 0.88 MAPT (0.47) NPC1RAB9AGRM4KMT2ASMN1; SMN2
SCHEMBL14083379 0.87 TRPV1 (0.55) NPC1RAB9AGRM4KMT2ASMN1; SMN2
SCHEMBL14083406 0.87 MAPT (0.53) RXFP1KMT2ATSHRMEN1MAPT
SCHEMBL14083245 0.87 RAB9A (0.58) NPC1RAB9AGRM4RXFP1KMT2A
SCHEMBL14083399 0.85 KCNQ3 (0.62) KMT2ASMN1; SMN2ALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 NPC1 1061/4885RAB9A 1914/4885GRM4 362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback